Research ArticleOriginal Article
Open Access
Impact of c-erb2 status on survival after high dose chemotherapy in high-risk breast cancer patients
Okan Kuzhan, Ahmet Ozet, Cuneyt Ulutin, Bulent Kurt, Seref Komurcu, Bekir Ozturk, Selmin Ataergin and Omer Gunhan
Saudi Medical Journal September 2007, 28 (9) 1374-1379;
Okan Kuzhan
Department of Medical Onclology Gulhane School of Medicine, Etlik, Ankara, Turkey.
Ahmet Ozet
Department of Medical Onclology Gulhane School of Medicine, Etlik, Ankara, Turkey.
Cuneyt Ulutin
Department of Medical Onclology Gulhane School of Medicine, Etlik, Ankara, Turkey.
Bulent Kurt
Department of Medical Onclology Gulhane School of Medicine, Etlik, Ankara, Turkey.
Seref Komurcu
Department of Medical Onclology Gulhane School of Medicine, Etlik, Ankara, Turkey.
Bekir Ozturk
Department of Medical Onclology Gulhane School of Medicine, Etlik, Ankara, Turkey.
Selmin Ataergin
Department of Medical Onclology Gulhane School of Medicine, Etlik, Ankara, Turkey.
Omer Gunhan
Department of Medical Onclology Gulhane School of Medicine, Etlik, Ankara, Turkey.
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Saudi Medical Journal
Vol. 28, Issue 9
1 Sep 2007
Impact of c-erb2 status on survival after high dose chemotherapy in high-risk breast cancer patients
Okan Kuzhan, Ahmet Ozet, Cuneyt Ulutin, Bulent Kurt, Seref Komurcu, Bekir Ozturk, Selmin Ataergin, Omer Gunhan
Saudi Medical Journal Sep 2007, 28 (9) 1374-1379;
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.